Skip to content
Recall Observatory FDA recall evidence

Device product

BioPlex 2200, Anti-CCP Reagent Pack, REF 665-3250, IVD

Z-1377-2023

February 21, 2023

Class II

Product summary

Firm
Bio-Rad Laboratories, Inc.
Event
Event 91854
Status
Ongoing
Classification
Class II
Quantity
1544 units
Official record key
device-enforcement:Z-1377-2023

Official wording

Reason: Bio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8  96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1  98.8%). The reduction in specificity may lead to an increase in the number of false positives.

Code information: Lot # 301481; UDI GTIN: 00847865000857

Distribution pattern: Worldwide distribution - US Nationwide and the countries of Canada, Czech Republic, Germany, Spain, France, United Kingdom, Israel, Italy, Norway, Sweden.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Bio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8  96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1  98.8%). The reduction in specificity may lead to an increase in the number of false positives.